ADDRESS: Street, City, Country
PHONE: +(123) 456 789
E-MAIL: your-email@mail.com
Aarogya Setu 2.0 provides a single, citizen-centric digital gateway for accessing health services. Read on to know the key features of the updated version…
imphoenix82
“The launch of these digital health initiatives marks another important step towards making healthcare more integrated, accessible and citizen-centric,” says J P Nadda.
imphoenix82
Applications are invited under two key sub-schemes to promote domestic manufacturing and innovation in the medical devices sector.
imphoenix82
AbbVie has received a positive CHMP opinion for upadacitinib (RINVOQ) to treat adults and adolescents with severe alopecia areata and non-segmental vitiligo, with a final European Commission decision expected in the coming months.
imphoenix82
Regional differences in skin concerns – Delhi recorded the worst firmness scores, Pune had the highest prevalence of dark circles, and Kolkata showed the highest levels of oiliness.
imphoenix82
Johnson & Johnson said the CHMP opinion is an important step towards positioning the off-the-shelf immunotherapy combination of teclistamab and daratumumab as a potential new standard of care earlier in the multiple myeloma treatment pathway.
imphoenix82
Alembic Pharmaceuticals announces USFDA final approval for Dapsone Gel, 5% and Oseltamivir Phosphate for Oral Suspension, 6 mg/mL.
dineshwori
The Ministry of Health and Family Welfare (MoHFW) has proposed amendments to the Drugs Rules, 1945 to introduce acknowledgement-based system for import of drugs for analytical and non-clinical testing.
imphoenix82
Zydus Lifesciences and Sunshine Healthcare have established a joint venture company to establish a pharma manufacturing facility in Sri Lanka.
imphoenix82
Intelivation Technologies plans to collaborate with surgeon partners while generating post-market clinical data to further evaluate the device performance.
imphoenix82HealthXplore is a digital platform dedicated to delivering insights into what’s new and what’s next in healthcare, pharmaceuticals, and medical innovation. We aim to bridge the gap between complex industry developments and informed audiences by presenting credible, timely, and engaging content.
Contact: +91 8447496924
HealthXploreIndia @2026. All Rights Reserved.
